Table I.
Sample number | Age | Gender | Pathological diagnosis |
---|---|---|---|
1 | 56 | M | NEE |
2 | 56 | M | NEE |
3 | 60 | M | NEE |
4 | 38 | F | NEE |
5 | 59 | F | NEE |
6 | 57 | F | LGIN |
7 | 69 | M | LGIN |
8 | 58 | F | LGIN |
9 | 59 | F | LGIN |
10 | 65 | M | HGIN |
11 | 52 | M | carcinoma in situ |
12 | 76 | M | T3N0/20M0 |
13 | 62 | M | T2N0/30M0 |
14 | 73 | M | T3N0/11M0 |
15 | 69 | M | T3N0/31M0 |
16 | 55 | F | T3N0/12M0 |
17 | 59 | F | T3N0/17M0 |
18 | 59 | M | T3N0/18M0 |
19 | 60 | M | T3N5/15M0 |
20 | 72 | F | T3N1/33M0 |
NEE, normal esophageal epithelium; LGIN, low-grade intraepithelial neoplasia; HGIN, high-grade intraepithelial neoplasia; M, male; F, female.